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The present case report describes a 27-year-old patient who presented with post-traumatic pleural 
effusion. Analysis of the pleural fluid showed hypereosinophilia (990 mm- 3), a decreased level of total 
complement, and decreased levels of C3 and C4 fractions (less than 50% of normal serum levels), 
indicating a local consumption mechanism for complement. Complement serum levels (CH50, C3, C4) 
were normal. All other aetiologic possibilities were eliminated. 
This case suggests that the immunopathological mechanism of post-traumatic pleural effusion may 
involve activation of the classical pathway of complement and a recruitment of inflammatory cells such 
as eosinophils. 
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Introduction 
The physiological mechanisms of post-traumatic 
pleural effusions are unknown. Various authors 
have found pleural and serum hypereosinophilia 
which could be the result of an immune complex 
reaction (l-3). However, to the authors’ knowl- 
edge, the levels of complement proteins have not 
been measured in any previous cases of hyper- 
eosinophilia. The present case report describes 
a young patient who presented with a post- 
traumatic pleural effusion: in which the differ- 
ence in serum and pleural levels of total 
complement and the C3 and C4 components 
evoked their local consumption. 
Case Report 
A 27-year-old patient was admitted to the 
authors’ clinic in March 1991 with left pleural 
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effusion. He was addicted to heroin and benzo- 
diazepines; he was a smoker (5 pack-years) and 
gave a history of a left tibia1 fracture in 1982. In 
December 1990 following a left thoracic trauma, 
he had left-sided chest pain. In February 1991, a 
chest X-ray was performed because of acute 
bronchitis and persistent left-sided chest pain, 
which showed left pleural effusion (Plate 1). 
There was no regression of the pleural effusion, 
despite antibiotic treatment. He was hospitalized 
in March 1991 to investigate this pleural effusion 
further. 
Laboratory analysis of his blood showed an 
absolute eosinophilic count of 900 mm - 3. There 
were signs of moderate inflammation, with an 
erythrocyte sedimentation rate of 27 mm at 1 h 
and 66 mm at 2 h, a fibrinogen level of 5.6 g l- ’ 
and a c-reactive protein level of 29 mg 1 - ‘. 
Hepatic and renal functions were normal. Anti- 
nuclear antibodies, circulating immune com- 
plexes and cryoglobulin were absent. Pulmonary 
ventilation and a perfusion scintigraphy scan 
were normal. A total of 300 ml of serohaematic 
exudative pleural fluid was obtained by 
aspiration. It contained 16% neutrophils, 
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PLATE 1. Chest X-ray at the patient’s admission. 
6% lymphocytes and 66% eosinophils. Pleural 
fluid proteins were 41 g 1 - ’ and glucose 
6.8 mm011 - ‘. The pleural fluid to serum lactate 
dehydrogenase ratio was 3: 1. There were neither 
Mycobacterium tuberculosis nor malignant cells 
on direct examination. 
Total complement haemolytic activity assay 
(CH50) (4), and C3 and C4 levels (measured by 
Nephelometry Laser, BNA Behring) in periph- 
eral blood and pleural fluid were measured twice 
over a period of 8 days, and are shown in Table 1. 
The patient was treated with oral antibiotics 
(penicillin A), mucolytics and chest physio- 
therapy. However, he left the hospital against 
medical advice. A chest X-ray performed in June 
1992, 15 months after his prior admission, 
showed total regression of the pleural effusion 
(Plate 2). 
Discussion 
The diagnosis of post-traumatic pleural effusion 
is guided by the history of trauma to the chest 
wall, with clinical signs of pleural effusion 
appearing secondarily. Absence of rib fracture 
does not rule out this possibility. Campbell et al. 
(1) reported cases of post-traumatic pleural 
effusion without rib fracture. This can also be 
diagnosed by a process of elimination, as in the 
present case, using clinical examination, lab- 
oratory examination of peripheral blood and 
pleural fluid, a pulmonary scintigraphy scan and 
radiological evolution to eliminate all other 
aetiological possibilities of pleural effusion, such 
as pulmonary embolism, malignancy, systemic 
diseases and empyema. 
The patient’s pleural fluid had two character- 
istics: hypereosinophilia, which is a classical 
phenomenon in this kind of pathology; and 
local consumption of complement. This combi- 
nation has not been reported previously. It has 
been reported that eosinophilic accumulation 
could be a response to the presence of immune 
complexes. Laster and Gleich (2) reported the 
presence of a chemotactic activity elicited by 
the IgG and IgM aggregates with the presence 
of complement. Cohen and Ward (3) reported 
the intervention of a chemotactic factor of 
TABLE 1. Serum and pleural complement levels 
Serum complement 
CH50* C31- C4f 
(UIml-l) (gl-‘) (kc”) 
Pleural complement 
CH50 
(UIll’) (g?) c4 (gll’) 
13 January 1991 51.5 0.87 0.22 20.5 0.35 0.086 
(0.43)5: (0.49)$ (0.33)4 
21 January 1991 39 0.76 0.20 (:647)$ 0.34 0.095 
(0.47)$ (0.36)f 
Normal serum levels 47* 12 0.71 f 0.19 0.26 f 0.13 
*Haemolytic assay. 
TLaser nephelometry, BNA Behring nephelometer. 
$Values in parentheses correspond to ratios of normal serum levels of CH50, C3 and C4. 
:^,*,>*A I/j_ .i.!lri rOl : , - *  /  
PLATE 2. Chest X-ray 15 months after 
hospitalization. 
eosinophils produced by a specific interaction 
of lymphocytes and immune complexes. 
Local consumption of pleural complement in 
pleural effusions has been shown by several. 
authors to be associated with rheumatoid arthri- 
tis and systemic lupus erythromatosus. In the 
study by Glowsky et al. (5), C3, C4 and CH50 
values in pleural fluid were less than 50% of 
blood values. Similarly, Migueres et al. (6) have 
shown local consumption of total complement 
and of the C3 fraction in purulent pleural effu- 
sion. The present patient’s exudative pleural 
fluid CH50, C3 and C4 levels varied between 33 
and 47% of the mean theoretical values in blood. 
In contrast, in lung cancer, pleural effusion and 
infections, pleural complement levels have been 
found to be greater than 50% of normal serum 
values. In two cases of rheumatoid arthritis 
presenting with pleural effusion, Pauli et al. (7) 
reported that the pleural fluid complement levels 
were less than 10% of normal blood values. A 
concomitant decrease of pleural fluid C3, C4 
levels has been reported in patients with rheuma- 
toid and lupus erythromatosus pleural effusion. 
However, Glowsky et al. did not find a decrease 
in the C3 fraction in such patients (5) 
In summary, the local consumption of comp- 
lement as observed in the present patient could 
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be similar to that found in rheumatoid arthritis 
and systemic lupus erythromatosus. This phe- 
nomenon could be related to the presence of 
immune complexes in the pleural fluid to the 
pericardial and synovial effusions found in these 
two systemic diseases (8,9). 
This finding suggests that the post-traumatic 
pleural effusion in the present patient could be 
the result of an immunological mechanism in 
which immune complexes’ immunoglobulin 
fractions activate the classical complement 
pathway and recruit inflammatory cells such as 
eosinophils. 
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